Literature DB >> 20071766

A gamma camera count rate saturation correction method for whole-body planar imaging.

Robert F Hobbs1, Sébastien Baechler, Srinivasan Senthamizhchelvan, Andrew R Prideaux, Caroline E Esaias, Melvin Reinhardt, Eric C Frey, David M Loeb, George Sgouros.   

Abstract

Whole-body (WB) planar imaging has long been one of the staple methods of dosimetry, and its quantification has been formalized by the MIRD Committee in pamphlet no 16. One of the issues not specifically addressed in the formalism occurs when the count rates reaching the detector are sufficiently high to result in camera count saturation. Camera dead-time effects have been extensively studied, but all of the developed correction methods assume static acquisitions. However, during WB planar (sweep) imaging, a variable amount of imaged activity exists in the detector's field of view as a function of time and therefore the camera saturation is time dependent. A new time-dependent algorithm was developed to correct for dead-time effects during WB planar acquisitions that accounts for relative motion between detector heads and imaged object. Static camera dead-time parameters were acquired by imaging decaying activity in a phantom and obtaining a saturation curve. Using these parameters, an iterative algorithm akin to Newton's method was developed, which takes into account the variable count rate seen by the detector as a function of time. The algorithm was tested on simulated data as well as on a whole-body scan of high activity Samarium-153 in an ellipsoid phantom. A complete set of parameters from unsaturated phantom data necessary for count rate to activity conversion was also obtained, including build-up and attenuation coefficients, in order to convert corrected count rate values to activity. The algorithm proved successful in accounting for motion- and time-dependent saturation effects in both the simulated and measured data and converged to any desired degree of precision. The clearance half-life calculated from the ellipsoid phantom data was calculated to be 45.1 h after dead-time correction and 51.4 h with no correction; the physical decay half-life of Samarium-153 is 46.3 h. Accurate WB planar dosimetry of high activities relies on successfully compensating for camera saturation which takes into account the variable activity in the field of view, i.e. time-dependent dead-time effects. The algorithm presented here accomplishes this task.

Entities:  

Mesh:

Year:  2010        PMID: 20071766      PMCID: PMC2844671          DOI: 10.1088/0031-9155/55/3/018

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  26 in total

1.  Correction of count losses due to deadtime on a DST-XLi (SmVi-GE) camera during dosimetric studies in patients injected with iodine-131.

Authors:  G Delpon; L Ferrer; A Lisbona; M Bardiès
Journal:  Phys Med Biol       Date:  2002-04-07       Impact factor: 3.609

2.  An activity quantification method based on registration of CT and whole-body scintillation camera images, with application to 131I.

Authors:  Katarina Sjögreen; Michael Ljungberg; Sven-Erik Strand
Journal:  J Nucl Med       Date:  2002-07       Impact factor: 10.057

Review 3.  The impact of PET and SPECT on dosimetry for targeted radionuclide therapy.

Authors:  Glenn Flux; Manuel Bardies; Myriam Monsieurs; Sauli Savolainen; Sven-Erik Strands; Michael Lassmann
Journal:  Z Med Phys       Date:  2006       Impact factor: 4.820

4.  Comparison of residence time estimation methods for radioimmunotherapy dosimetry and treatment planning--Monte Carlo simulation studies.

Authors:  B He; R L Wahl; Y Du; G Sgouros; H Jacene; I Flinn; E C Frey
Journal:  IEEE Trans Med Imaging       Date:  2008-04       Impact factor: 10.048

5.  Update on hybrid conjugate-view SPECT tumor dosimetry and response in 131I-tositumomab therapy of previously untreated lymphoma patients.

Authors:  Kenneth F Koral; Yuni Dewaraja; Jia Li; Qiang Lin; Denise D Regan; Kenneth R Zasadny; Stephen G Rommelfanger; Issac R Francis; Mark S Kaminski; Richard L Wahl
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

6.  Comparison of four scatter correction methods for patient whole-body imaging during therapeutic trials with iodine-131.

Authors:  Grégory Delpon; Ludovic Ferrer; Corinne Lenta; Albert Lisbona; Iréne Buvat; Manuel Bardiès
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

7.  A practical dead time correction method in planar activity quantification for dosimetry during radionuclide therapy.

Authors:  C Chiesa; A Negri; C Albertini; R Azzeroni; E Setti; L Mainardi; G Aliberti; E Seregni; E Bombardieri
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-10-07       Impact factor: 2.346

Review 8.  Three-dimensional imaging-based radiobiological dosimetry.

Authors:  George Sgouros; Eric Frey; Richard Wahl; Bin He; Andrew Prideaux; Robert Hobbs
Journal:  Semin Nucl Med       Date:  2008-09       Impact factor: 4.446

9.  Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.

Authors:  David M Loeb; Elizabeth Garrett-Mayer; Robert F Hobbs; Andrew R Prideaux; George Sgouros; Ori Shokek; Moody D Wharam; Tammy Scott; Cindy L Schwartz
Journal:  Cancer       Date:  2009-06-01       Impact factor: 6.860

10.  Impact of scatter and attenuation corrections for iodine-131 two-dimensional quantitative imaging in patients.

Authors:  Grégory Delpon; Ludovic Ferrer; Albert Lisbona; Manuel Bardiès
Journal:  Cancer Biother Radiopharm       Date:  2003-04       Impact factor: 3.099

View more
  6 in total

1.  EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting.

Authors:  M Lassmann; C Chiesa; G Flux; M Bardiès
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-27       Impact factor: 9.236

2.  Multi-centre evaluation of accuracy and reproducibility of planar and SPECT image quantification: An IAEA phantom study.

Authors:  Brian E Zimmerman; Darko Grošev; Irène Buvat; Marco A Coca Pérez; Eric C Frey; Alan Green; Anchali Krisanachinda; Michael Lassmann; Michael Ljungberg; Lorena Pozzo; Kamila Afroj Quadir; Mariella A Terán Gretter; Johann Van Staden; Gian Luca Poli
Journal:  Z Med Phys       Date:  2016-04-19       Impact factor: 4.820

3.  A treatment planning method for sequentially combining radiopharmaceutical therapy and external radiation therapy.

Authors:  Robert F Hobbs; Todd McNutt; Sébastien Baechler; Bin He; Caroline E Esaias; Eric C Frey; David M Loeb; Richard L Wahl; Ori Shokek; George Sgouros
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-13       Impact factor: 7.038

4.  Tumor dosimetry and response for 153Sm-ethylenediamine tetramethylene phosphonic acid therapy of high-risk osteosarcoma.

Authors:  Srinivasan Senthamizhchelvan; Robert F Hobbs; Hong Song; Eric C Frey; Zhe Zhang; Elwood Armour; Richard L Wahl; David M Loeb; George Sgouros
Journal:  J Nucl Med       Date:  2012-01-17       Impact factor: 10.057

5.  Strengths and Weaknesses of a Planar Whole-Body Method of (153)Sm Dosimetry for Patients with Metastatic Osteosarcoma and Comparison with Three-Dimensional Dosimetry.

Authors:  Donika Plyku; David M Loeb; Andrew R Prideaux; Sébastien Baechler; Richard L Wahl; George Sgouros; Robert F Hobbs
Journal:  Cancer Biother Radiopharm       Date:  2015-11       Impact factor: 3.099

6.  Beyond Palliation: Therapeutic Applications of 153Samarium-EDTMP.

Authors:  Breelyn A Wilky; David M Loeb
Journal:  Clin Exp Pharmacol       Date:  2013-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.